A single acute pharmacological dose of γ-hydroxybutyrate modifies multiple gene expression patterns in rat hippocampus and frontal cortex

Physiological Genomics

Volumn 41, Issue 2, 2010, Pages 146-160

  Kemmel, Véronique ^a   Klein, Christian ^a   Dembélé, Doulaye ^c   Jost, Bernard ^c   Taleb, Omar ^a   Aunis, Dominique ^b   Mensah Nyagan, Ayikoe G ^a   Maitre, Michel ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b INSERM   (France)

^c INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Neuroprotection and cell signaling; Potentiation of brain aminobutyric acid synapses; Sleep and anesthesia

Indexed keywords

4 HYDROXYBUTYRIC ACID; TRANSCRIPTOME;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FRONTAL CORTEX; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; HIPPOCAMPUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; UNINDEXED SEQUENCE;

ANIMALS; BLOTTING, WESTERN; CENTRAL NERVOUS SYSTEM AGENTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREFRONTAL CORTEX; RATS; RATS, WISTAR; RNA, MESSENGER; SODIUM OXYBATE; TRANSCRIPTION, GENETIC;

RATTUS;

EID: 77951188459     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00208.2009     Document Type: Article

References (73)

1. Adelsberger H, Brunswieck S, Dudel J. Modulatory effects of gamma-hydroxybutyric acid on a GABAA receptor from crayfish muscle. Eur J Pharmacol 350: 317-323, 1998.
2. Andriamampandry C, Taleb O, Kemmel V, Humbert JP, Aunis D, Maitre M. Cloning and functional characterization of a gamma-hydroxybutyrate receptor identified in the human brain. FASEB J 21: 885-895, 2007.
3. Andriamampandry C, Taleb O, Viry S, Muller C, Humbert JP, Gobaille S, Aunis D, Maitre M. Cloning and characterization of a rat brain receptor that binds the endogenous neuromodulator gamma-hydroxybutyrate (GHB). FASEB J 17: 1691-1693, 2003.
4. Axelson H. The Notch signaling cascade in neuroblastoma: role of the basic helix-loop-helix proteins HASH-1 and HES-1. Cancer Lett 204: 171-178, 2004.
5. Banerjee PK, Tillakaratne NJ, Brailowsky S, Olsen RW, Tobin AJ, Snead OC 3rd. Alterations in GABAA receptor alpha1 and alpha4 subunit mRNA levels in thalamic relay nuclei following absence-like seizures in rats. Exp Neurol 154: 213-223, 1998.
6. Benavides J, Rumigny JF, Bourguignon JJ, Cash C, Wermuth CG, Mandel P, Vincendon G, Maitre M. High affinity binding sites for gamma-hydroxybutyric acid in rat brain. Life Sci 30: 953-961, 1982.
7. Bendova Z, Sumova S. Photoperiodic regulation of PER1 and PER2 protein expression in rat peripheral tissues. Physiol Res 55: 623-632, 2006.
8. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125: 279-284, 2001.
9. Brancucci A, Berretta N, Mercuri NB, Francesconi W. Presynaptic modulation of spontaneous inhibitory postsynaptic currents by gamma-hydroxybutyrate in the substantia nigra pars compacta. Neuropsychopharmacology 29: 537-543, 2004. (Pubitemid 38365930)
10. A-mediated inhibitory postsynaptic potentials in the CA1 region of hippocampus. Neuropsychopharmacology 27: 960-969, 2002.
11. Cash CD, Gobaille S, Kemmel V, Andriamampandry C, Maitre M. Gamma-hydroxybutyrate receptor function studied by the modulation of nitric oxide synthase activity in rat frontal cortex punches. Biochem Pharmacol 58: 1815-1819, 1999.
12. Castelli MP. Multi-faceted aspects of gamma-hydroxybutyric acid: a neurotransmitter, therapeutic agent and drug of abuse. Mini Rev Med Chem 8: 1188-1202, 2008.
13. Castelli MP, Mocci I, Langlois X, Gommerendagger W, Luyten WH, Leysen JE, Gessa GL. Quantitative autoradiographic distribution of gamma-hydroxybutyric acid binding sites in human and monkey brain. Brain Res 78: 91-99, 2000.
14. Charles CH, Sun H, Lau LF, Tonks NK. The growth factor-inducible immediate-early gene 3CH134 encodes a protein-tyrosine-phosphatase. Proc Natl Acad Sci USA 90: 5292-5296, 1993.
15. Cinar B, Fang PK, Lutchman M, Di Vizio D, Adam RM, Pavlova N, Rubin MA, Yelick PC, Freeman MR. The pro-apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1. EMBO J 26: 4523-4534, 2007.
16. B receptors in the mediation of discriminative stimulus effects of gamma-hydroxybutyric acid. Physiol Behav 64: 293-302, 1998.
17. Cortes-Canteli M, Luna-Medina R, Sanz-Sancristobal M, Alvarez-Barrientos A, Santos A, Perez-Castillo A. CCAAT/enhancer binding protein beta deficiency provides cerebral protection following excitotoxic injury. J Cell Sci 121: 1224-1234, 2008.
18. Crunelli V, Emri Z, Leresche N. Unravelling the brain targets of gamma-hydroxybutyric acid. Curr Opin Pharmacol 6: 44-52, 2006.
19. DeSteno DA, Schmauss C. Induction of early growth response gene 2 expression in the forebrain of mice performing an attention-set-shifting task. Neuroscience 152: 417-428, 2008.
20. Dey A, Chitsaz F, Abbasi A, Misteli T, Ozato K. The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis. Proc Natl Acad Sci USA 100: 8758-8763, 2003.
21. Diana M, Mereu G, Mura A, Fadda F, Passino N, Gessa G. Low doses of gamma-hydroxybutyric acid stimulate the firing rate of dopaminergic neurons in unanesthetized rats. Brain Res 566: 208-211, 1991.
22. Ehrhardt JD, Vayer P, Maitre M. A rapid and sensitive method for the determination of gamma-hydroxybutyric acid and trans-gamma-hydroxycrotonic acid in rat brain tissue by gas chromatography/mass spectrometry with negative ion detection. Biomed Environ Mass Spectrom 15: 521-524, 1988.
23. A receptors alpha4 subunit mRNA abundance induced by ethanol withdrawal in cerebellar granule cells. Mol Pharmacol 63: 896-907, 2003.
24. Gabor R, Regunathan S, Sourkes TL. Central regulation of adrenal tyrosine hydroxylase: interaction between dopamine and GABA systems. Neuropharmacology 28: 521-527, 1989.
25. Gao B, Kilic E, Baumann CR, Hermann DM, Bassetti CL. Gammahydroxybutyrate accelerates functional recovery after focal cerebral ischemia. Cerebrovasc Dis 26: 413-419, 2008.
26. B receptor agonist baclofen. Physiol Genomics 22: 93-98, 2005.
27. Giorgi O, Rubio MC. Decreased 3H-L-quinuclidinyl benzilate binding and muscarine receptor subsensitivity after chronic gamma-butyrolactone treatment. Naunyn Schmiedebergs Arch Pharmacol 318: 14-18, 1981.
28. Gobaille S, Hechler V, Andriamampandry C, Kemmel V, Maitre M. Gamma-hydroxybutyrate modulates synthesis and extracellular concentration of gamma-aminobutyric acid in discrete rat brain regions in vivo. J Pharmacol Exp Ther 290: 303-309, 1999.
29. Gobaille S, Schmidt C, Cupo A, Herbrecht F, Maitre M. Characterization of methionine-enkephalin release in the rat striatum by in vivo dialysis: effects of gamma-hydroxybutyrate on cellular and extracellular methionine-enkephalin levels. Neuroscience 60: 637-648, 1994.
30. 2+-regulated exocytosis in neuroendocrine cells. J Biol Chem 276: 9726-9732, 2001.
31. Hechler V, Gobaille S, Maitre M. Selective distribution pattern of gamma-hydroxybutyrate receptors in the rat forebrain and midbrain as revealed by quantitative autoradiography. Brain Res 572: 345-348, 1992.
32. 3H]hydroxybutyrate binding sites as determined by quantitative autoradiography. J Neurochem 49: 1025-1032, 1987.
33. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57, 2009.
34. Huo JS, McEachin RC, Cui TX, Duggal NK, Hai T, States DJ, Schwartz J. Profiles of growth hormone (GH)-regulated genes reveal time-dependent responses and identify a mechanism for regulation of activating transcription factor 3 by GH. J Biol Chem 281: 4132-4141, 2006.
35. +/NADH ratio in CHO cells by stable transfection with human cytosolic glycerol-3-phosphate dehydrogenase: resistance to oxidative stress. Mol Cells 9: 429-435, 1999.
36. Imperato A, Dazzi L, Carta G, Colombo G, Biggio G. Rapid increase in basal acetylcholine release in the hippocampus of freely moving rats induced by withdrawal from long-term ethanol intoxication. Brain Res 784: 347-350, 1998.
37. Iso T, Kedes L, Hamamori Y. HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol 194: 237-255, 2003.
38. Kamei Y, Yuba S, Nakayama T, Yoneda Y. Three distinct classes of the alpha-subunit of the nuclear pore-targeting complex (importin-alpha) are differentially expressed in adult mouse tissues. J Histochem Cytochem 47: 363-372, 1999.
39. Kaupmann K, Cryan JF, Wellendorph P, Mombereau C, Sansig G, Klebs K, Schmutz M, Froestl W, van der Putten H, Mosbacher J, Brauner-Osborne H, Waldmeier P, Bettler B. Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gammahydroxybutyrate in GABAB1-deficient mice. Eur J Neurosci 18: 2722-2730, 2003.
40. Kemmel V, Miehe M, Roussel G, Taleb O, Nail-Boucherie K, Marchand C, Stutz C, Andriamampandry C, Aunis D, Maitre M. Immunohistochemical localization of a GHB receptor-like protein isolated from rat brain. J Comp Neurol 498: 508-524, 2006.
41. Kemmel V, Taleb O, Andriamampandry C, Aunis D, Maitre M. Gamma-hydroxybutyrate receptor function determined by stimulation of rubidium and calcium movements from NCB-20 neurons. Neuroscience 116: 1021-1031, 2003.
42. Klein C, Kemmel V, Taleb O, Aunis D, Maitre M. Pharmacological doses of gamma-hydroxybutyrate (GHB) potentiate histone acetylation in the rat brain by histone deacetylase inhibition. Neuropharmacology 57: 137-147, 2009.
43. Kokkinakis DM, Liu X, Chada S, Ahmed MM, Shareef MM, Singha UK, Yang S, Luo J. Modulation of gene expression in human central nervous system tumors under methionine deprivation-induced stress. Cancer Res 64: 7513-7525, 2004.
44. Kurima K, Yang Y, Sorber K, Griffith AJ. Characterization of the transmembrane channel-like (TMC) gene family: functional clues from hearing loss and epidermodysplasia verruciformis. Genomics 82: 300-308, 2003.
45. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 98: 31-36, 2001.
46. B receptors. Neuropharmacology 38: 1667-1673, 1999.
47. Ma ZL, Gu XP, Zeng YM, Zhang Y. Effect of sodium hydroxybutyrate on the expression of hippocampal N -methyl-D-aspartate receptor 2B subunit mRNA in neonatal rats with hypoxic-ischemic insult. Ann Clin Lab Sci 36: 307-311, 2006.
48. Maitre M. The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Prog Neurobiol 51: 337-361, 1997.
49. Maitre M, Andriamampandry C, Kemmel V, Schmidt C, Hode Y, Hechler V, Gobaille S. Gamma-hydroxybutyric acid as a signaling molecule in brain. Alcohol 20: 277-283, 2000.
50. Muller C, Viry S, Miehe M, Andriamampandry C, Aunis D, Maitre M. Evidence for a gamma-hydroxybutyrate (GHB) uptake by rat brain synaptic vesicles. J Neurochem 80: 899-904, 2002.
51. Ottani A, Saltini S, Bartiromo M, Zaffe D, Renzo Botticelli A, Ferrari A, Bertolini A, Genedani S. Effect of gamma-hydroxybutyrate in two rat models of focal cerebral damage. Brain Res 986: 181-190, 2003.
52. Pardi D, Black J. Gamma-hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness. CNS Drugs 20: 993-1018, 2006.
53. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates . New York: Academic, 1986.
54. Pedraza C, Garcia FB, Navarro JF. Neurotoxic effects induced by gammahydroxybutyric acid (GHB) in male rats. Int J Neuropsychopharmacol 1-13, 2009.
55. Ren X, Mody I. Gamma-hydroxybutyrate induces cyclic AMP-responsive element-binding protein phosphorylation in mouse hippocampus: an involvement of GABAB receptors and cAMP-dependent protein kinase activation. Neuroscience 141: 269-275, 2006.
56. Ren X, Mody I. Gamma-hydroxybutyrate reduces mitogen-activated protein kinase phosphorylation via GABA B receptor activation in mouse frontal cortex and hippocampus. J Biol Chem 278: 42006-42011, 2003.
57. Reppert SM, Weaver DR. Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol 63: 647-676, 2001.
58. Scharf MB. Sodium oxybate for narcolepsy. Expert Rev Neurother 6: 1139-1146, 2006.
59. Schmidt-Mutter C, Muller C, Zwiller J, Gobaille S, Maitre M. Gamma-hydroxybutyrate and cocaine administration increases mRNA expression of dopamine D1 and D2 receptors in rat brain. Neuropsychopharmacology 21: 662-669, 1999.
60. Sethy VH, Roth RH, Walters JR, Marini J, Van Woert MH. Effect of anesthetic doses of gamma-hydroxybutyrate on the acetylcholine content of rat brain. Naunyn Schmiedebergs Arch Pharmacol 295: 9-14, 1976.
61. Shiratsuchi T, Nishimori H, Ichise H, Nakamura Y, Tokino T. Cloning and characterization of BAI2 and BAI3, novel genes homologous to brain-specific angiogenesis inhibitor 1 (BAI1). Cytogenet Cell Genet 79: 103-108, 1997.
62. Snead OC 3rd, Nichols AC. Gamma-hydroxybutyric acid binding sites: evidence for coupling to a chloride anion channel. Neuropharmacology 26: 1519-1523, 1987.
63. Sweatt JD. Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol 14: 311-317, 2004.
64. Takahara J, Yunoki S, Yakushiji W, Yamauchi J, Yamane Y. Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans. J Clin Endocrinol Metab 44: 1014-1017, 1977.
65. Teng CH, Huang WN, Meng TC. Several dual specificity phosphatases coordinate to control the magnitude and duration of JNK activation in signaling response to oxidative stress. J Biol Chem 282: 28395-28407, 2007.
66. Tergaonkar V. NFkappaB pathway: a good signaling paradigm and therapeutic target. Int J Biochem Cell Biol 38: 1647-1653, 2006.
67. Tsai KJ, Chen SK, Ma YL, Hsu WL, Lee EH. sgk, a primary glucocorticoid-induced gene, facilitates memory consolidation of spatial learning in rats. Proc Natl Acad Sci USA 99: 3990-3995, 2002.
68. Uemura N, Hisano S, Fukui Y. Induction of Fos-like immunoreactivity in the lower brainstem and the spinal cord of the rat by intraperitoneal administration of an endogenous satiety substance, 2-buten-4-olide. Neurosci Lett 227: 131-134, 1997.
69. van Nieuwenhuijzen PS, McGregor IS, Hunt GE. The distribution of gamma-hydroxybutyrate-induced Fos expression in rat brain: comparison with baclofen. Neuroscience 158: 441-455, 2009.
70. Vayer P, Mandel P, Maitre M. Gamma-hydroxybutyrate, a possible neurotransmitter. Life Sci 41: 1547-1557, 1987.
71. Volpi R, Chiodera P, Caffarra P, Scaglioni A, Malvezzi L, Saginario A, Coiro V. Muscarinic cholinergic mediation of the GH response to gamma-hydroxybutyric acid: neuroendocrine evidence in normal and parkinsonian subjects. Psychoneuroendocrinology 25: 179-185, 2000.
72. Webster MK, Goya L, Ge Y, Maiyar AC, Firestone GL. Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum. Mol Cell Biol 13: 2031-2040, 1993.
73. Wong CG, Gibson KM, Snead OC 3rd. From the street to the brain: neurobiology of the recreational drug gamma-hydroxybutyric acid. Trends Pharmacol Sci 25: 29-34, 2004.